Sandoz Group AG (VIE:SDZ)

Market Cap	28.76B +52.5%
Revenue (ttm)	9.01B +4.7%
Net Income	193.29M
EPS	0.45
Shares Out	n/a
PE Ratio	148.81
Forward PE	20.81
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	22
Open	67.08
Previous Close	66.98
Day's Range	66.94 - 67.08
52-Week Range	52.52 - 69.04
Beta	n/a
RSI	48.72
Earnings Date	Feb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 20,000
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: SDZ

Financial Performance

Financial numbers in USD